| Cash and cash equivalents |
74.38M |
| Receivable from Perseid |
| Available-for-sale investment in equity securities |
22K |
| Prepaid expenses and other current assets |
199K |
| Assets of discontinued operations |
| Total current assets |
79.6M |
| Property and equipment, net |
87K |
| Other noncurrent assets |
| Total assets |
79.69M |
| Accounts payable |
381K |
| Accrued compensation |
2.14M |
| Distribution payable |
607K |
| Other accrued liabilities |
297K |
| Liabilities of discontinued operations |
| Total current liabilities |
3.43M |
| Non-current distribution payable |
| Other non-current liabilities |
52K |
| Commitments and contingencies (Notes 4 and 5) |
0 |
| Preferred stock, $0.0001 par value, 5,000,000 shares authorized, no shares issued and outstanding at December 31, 2010 and June 30, 2011 |
0 |
| Common stock, $0.0001 par value, 100,000,000 shares authorized, 29,210,411 and 29,209,964 shares issued and outstanding at December 31, 2010 and June 30, 2011, respectively |
3K |
| Additional paid-in capital |
213.17M |
| Accumulated other comprehensive income |
23K |
| Accumulated deficit |
-136.98M |
| Total Maxygen, Inc. stockholders' equity |
| Non-controlling interests |
| Total stockholders' equity |
76.21M |
| Total liabilities and stockholders' equity |
79.69M |
